DDW: HBV, tuberculosis reactivations rare in IBD patients on biologic therapy

His financial disclosures include receiving consulting, speaking, teaching, and/or advisory fees from Janssen, Aptalis, and AbbVie.

emechcatie@frontlinemedcom.com